Why does the inclusion of migrant populations and ethnic groups make sense? Lisbon, 7 june 2007 Dr Srdan Matic, Regional Adviser STI/HIV & AIDS, WHO Regional.

Slides:



Advertisements
Similar presentations
Antiretroviral Therapy Standard Core Indicators. Emergency Plan for AIDS Relief 2 million people reached with ART 7 million new infects prevented 10 million.
Advertisements

HIV/ AIDS - Yemen Successes and challenges Dr. Fouzia Abdullah Gharama Programme Manager Ministry of Public Health & Population.
Scaling up HIV services for women and children achievements and challenges e-lluminate session e-lluminate session Yves Souteyrand 2 March 2010.
Supporting community action on AIDS in developing countries Supporting community action on AIDS in India Children Affected By AIDS in Low and Concentrated.
HIV/AIDS Weakens the Immune System
TB/HIV Research Priorities in Resource- Limited Settings Where we are now and some suggestions for where to go Paul Nunn February 2005.
Strategic Information for Anti-RetroViral Treatment Programmes Workshop WHO and UNAIDS Geneva June 30- July Ties Boerma HIV Department Surveillance,
How Universal will Universal Access be in Europe by 2010? Eddy Beck Evaluation Department UNAIDS, Geneva
HIV in Europe Stockholm, 3.November 2009 Communication on combating HIV/AIDS in the EU and the neighbourhood - strategy and second action plan ( )
 HIV in Europe November 2009, Stockholm The Momentum ensued since 2007 – The Need for Political Action? HIV Portugal - Follow-up and community priorities.
Unprevented and prevented HIV cases in Europe and Central Asia Unprevented and prevented HIV cases in Europe and Central Asia Ani SHAKARISHVILI, MD UNAIDS.
European Network for HIV/STI Prevention and Health Promotion among Migrant Sex Workers Access to Services and Rights for sex workers.
Slide 2 Key Points Although HIV/AIDS is found throughout the world, most people living with HIV/AIDS reside in low- and middle-income countries More people.
Monitoring and Evaluation Frameworks   What is an M&E Framework?   Why do we use M&E Frameworks?   How do we develop M&E Frameworks? MEASURE Evaluation.
GAP Report 2014 Migrants People left behind: Migrants Link with the pdf, Migrants.
People left behind: People living with HIV
Washington D.C., USA, July 2012www.aids2012.org Addressing the intersection of criminalisation, discrimination and stigma Susan Timberlake Chief,
2012 HIV/AIDS surveillance in Europe European Centre for Disease Prevention and Control, Stockholm WHO Regional Office for Europe, Copenhagen.
HIV/AIDS Treatment and Care Clinical protocols for the WHO European Region 23 November 2007 World AIDS Day Jeffrey V. Lazarus WHO Europe, STI/HIV/AIDS.
 Insufficient Reliable data in this region  Estimated people living with HIV  The number of new HIV infections in the region increased.
HIV/AIDS in Prison Settings Dr. Monica Beg HIV/AIDS Unit, United Nations Office on Drugs and Crime, Krakow, Poland September 27, 2004.
IMPACT OF HIV/AIDS ON THE WORLD OF WORK
HIV/AIDS: A Global and Regional Perspective AIDS in Post 2015 Development Agenda.
HIV/AIDS STI & Viral Hepatitis WHO/Europe HIV/HCV coinfection in Europe Dr Irina Eramova August 4, 2008 XVII International AIDS Conference, Mexico.
Unit 8: Uses and Dissemination of HIV Sentinel Surveillance Data #3-8-1.
Child and Adolescent Health and Development RHR RHR Guidance of WHO on safe abortion FIAPAC, Moscow October 28, 2005 G. Lazdane Regional Adviser RHR WHO.
© Prof. Rifat Atun. Imperial College London, 2007 The Dublin Declaration Beyond Promises Imperial College London 23 rd November 2007 Professor Rifat Atun.
2009 ECONOMIC AND SOCIAL COUNCIL ANNUAL MINISTERIAL REVIEW HIV in Latin America and the Caribbean Implementing agreed goals and commitments César Antonio.
Opportunities and Obligations for Disability Inclusion in the UNAIDS Investment Framework Dr. Jill Hanass-Hancock Health Economics and HIV and AIDS Research.
Return on investment: How do whole societies benefit from improved services and coverage for key populations? Bradley Mathers Kirby Institute UNSW Australia.
Sexual transmission of HIV amongst migrant populations in Europe: managing change in surveillance, interventions and prevention V.Delpech and Teymur Noori.
‘Gaps in the global HIV/AIDS success story Copenhagen December 2 nd 2013 Gaps in the global HIV/AIDS success story Briefing on HIV/AIDS in Europe Martin.
XVII INTERNATIONAL AIDS CONFERENCE PANCAP Satellite Meeting Hon Douglas Slater, Minister of Health, St. Vincent and the Grenadines.
HIV and STI Department, Health Protection Agency - Colindale HIV and AIDS Reporting System The threshold for an ART secondary prevention effect on HIV.
Central Asia Regional Health Security Workshop George C. Marshall European Center for Security Studies April 2012, Garmisch-Partenkirchen, Germany.
Providing HIV services to key affected populations in MENA: outreach workers under threat P RESENTED BY D R. W ESSAM E L B EIH, COUNTRY COORDINATOR, E.
Ecdc.europa.eu Epidemiological Situation of HIV/AIDS in the EU and its Neighbouring Countries German Presidency Conference Responsibility & Partnership.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Bhutan Last updated: January 2016.
HIV and AIDS Data Hub for Asia-Pacific Review in slides Mongolia Last updated: December 2014.
Advisory Forum November 28th-29th 2005 HIV, AIDS and Other Sexually Transmitted and Blood Borne Infections Prof Angus Nicoll SNE - HIV & STI Co-ordinator.
2008 International AIDS Conference UNGASS reporting Matthew Warner-Smith Monitoring and Evaluation Division UNAIDS 2008 International AIDS Conference Satellite.
Harm reduction evidence: Eastern Europe and Central Asia Raminta Stuikyte Central and Eastern European Harm Reduction Network.
1 06/06 e Global HIV epidemic, 1990 ‒ 2005*HIV epidemic in sub-Saharan Africa, 1985 ‒ 2005* Number of people living with HIV % HIV prevalence, adult (15-49)
TB AND HIV: “THE STRATEGIC VISION FOR THE COUNTRY” Dr Lindiwe Mvusi 18 May 2012 MMPA Congress 2012.
Moving from a commodity approach: “Fund some of everything” or “Fund what is comfortable” to An Investment approach: “Fund evidenced-based activities.
Introduction to the NMSF The National Multi-Sectoral Strategic Framework (NMSF) on HIV&AIDS  Translates the National Policy of HIV&AIDS. 
Contents - HIV global slides
Overview of Global HIV Epidemic
Bhutan Last updated: September 2016.
Mongolia Last updated: April 2016.
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Global epidemiology of injecting drug use
People who inject drugs
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
Monitoring the implementation of the TB Action Plan for the WHO European Region, 2016–2020 EU/EEA situation in 2016 ECDC Tuberculosis Programme European.
WHO HIV update July 2018 Global epidemic Global progress and cascade
Contents - HIV global slides
Migrants Dr Julia del Amo National Center for Epidemiology
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS Surveillance in Europe
HIV/AIDS Surveillance in Europe 2011 HIV/AIDS surveillance in Europe
AIDS-related deaths the lowest this century
Hidden Opportunities - What Will It Take to Reach in Eastern Europe?
Contents - HIV global slides
Presentation for Second Meeting of the Global TB/HIV Working Group
Collaborative TB/HIV activities in European Region
Contents - HIV global slides
Geneva, Switzerland June 2002
Issues on the current information system
Bhutan Last updated: July 2018.
Regional HIV and AIDS statistics and features, end of 2004
Presentation transcript:

Why does the inclusion of migrant populations and ethnic groups make sense? Lisbon, 7 june 2007 Dr Srdan Matic, Regional Adviser STI/HIV & AIDS, WHO Regional Office for Europe

STI/HIV/AIDS Programme WHO/Europe 2 ”I am a migrant and member of an ethnic minority”

STI/HIV/AIDS Programme WHO/Europe 3 Evidence There is limited direct scientific evidence from research demonstrating benefit, or lack of benefit of interventions specifically provided to migrants or ethnic minorities There is plenty of evidence that universal access/coverage has a beneficial impact on health outcomes

STI/HIV/AIDS Programme WHO/Europe 4 Annual number of newly reported cases – all WHO EURO countries, 31/12/06 * Preliminary and incomplete data WHO/UNAIDS estimates, end of 2005: PLWHA: 2,320,000 (1.56 – 3.19m) Estimated prevalence: 0.51% (range: %) Number of cases reported to WHO EURO (31/12/06): New HIV infections: New AIDS cases: New AIDS deaths:

STI/HIV/AIDS Programme WHO/Europe 5 HIV cases by country of origin, 2005 Country of origin Western Europe Central and Eastern Europe SSAOtherUnknown West37.3%2.5%1.6%24.1%5.6%29.1% Centre86.3%0.8%4.6%0.8%1.8%5.7% East99.7%0.0%0.3%0.0%

STI/HIV/AIDS Programme WHO/Europe 6 Impact of HAART on prevention Positive effect (decreased morbidity and mortality; increased survival) of HAART continues, including a lower average amount of circulating virus per infected individual since the introduction of HAART A virus concentration below the detection limit is reached in an increasing number of patients on HAART The HIV transmission probability in the population has decreased as a result of the lower amount of HIV circulating Source: HIV Monitoring Foundation, Amsterdam

STI/HIV/AIDS Programme WHO/Europe 7 Principles of good public health Social justice – giving a just treatment and a just share of societal benefits to all groups and individuals Civil and human rights of individuals (right to life, to health, to education,....) Health as human, social and economic right Principle of non-dicrimination based on race, ethnicity, origin, etc.

STI/HIV/AIDS Programme WHO/Europe 8 Right or wrong? We should do what is right European countries committed to Universal access to HIV prevention, treatment and care (Dublin, Vilnius, Bremen)

STI/HIV/AIDS Programme WHO/Europe 9 1.Exclusion is directly opposed to the objectives of public health approaches to HIV and STI prevention, treatment and care and undermine public health messages 2.It increases stigma and discrimination of people vulnerable to HIV 3.It increases stigma and discrimination of migrants and ethnic minorities 4.It creates disincentives for HIV and STI testing and counselling, and people die as consequence 5.It increases vulnerability and creates incentives for unsafe behaviour 6.It violates fundamental principles of international human rights law 7.Exclusion is not evidence based Conclusions